DSB-Induced ssBIR in Fully Grown Mouse Oocytes

2026-08-28

The reference study identifies short-scale break-induced replication (ssBIR) as a DNA damage response in fully grown mouse oocytes and shows that this process can amplify double-strand-break signals. Its inhibitor-based design links ssBIR to Rad51 and DNA polymerase activity, providing a useful framework for studying replication-associated genome instability in germ cells.

Protecting Plant Protein Readouts in m6A–Virus Research

2026-08-27

Plant-virus studies increasingly depend on connecting RNA modification biology with intact protein interactions. This thought-leadership article explains how disciplined protein degradation inhibition, enabled by an EDTA-free broad-spectrum cocktail, can strengthen mechanistic interpretation of m6A-mediated antiviral defense without overstating what a protease inhibitor can preserve.

Niclosamide Workflows for STAT3 Cancer Research

2026-08-27

Build reproducible STAT3-centered experiments with Niclosamide, from solution preparation and dose-response mapping to orthogonal apoptosis and cell-cycle validation. The workflow also shows how a time-course and fractionation strategy from a parasitology study can improve assay design without overstating cross-domain evidence.

GluN2A/2B Control Connexins in TMJ Allodynia

2026-08-26

This study identifies distinct roles for GluN2A and GluN2B in trigeminal ganglion sensitization during temporomandibular joint inflammation. Its genetic and cellular experiments connect NMDAR activity with connexin and pannexin regulation through ERK1/2, MAPK, PKA, and PKC signaling, providing a mechanistic framework for orofacial inflammatory allodynia research.

Fulvestrant (ICI 182,780): From ER Biology to Translation

2026-08-26

An evidence-led strategy for using Fulvestrant (ICI 182,780) to connect ERα degradation, MDM2 protein degradation, chemotherapy sensitization, and endocrine–immune biology while distinguishing established findings from translational hypotheses.

Catalpol in Diabetes: Pharmacology, PK, and Safety

2026-08-25

Bai and colleagues reviewed more than 100 publications to evaluate Catalpol, also encountered as Catalpinoside, across diabetes, diabetic complications, pharmacokinetics, and safety. Their central contribution is an integrated view of Catalpol as a multitarget iridoid glycoside with preclinical effects on glucose metabolism, inflammation, oxidative stress, apoptosis, and tissue injury, while emphasizing the limits of translating heterogeneous animal evidence to clinical use.

ICOS Signaling and Th2 Differentiation in Allergic Rhinitis

2026-08-25

GS967 Cardiac Late Sodium Current Inhibitor Workflows

2026-08-24

GS967 enables targeted control of pathological late sodium influx in ventricular myocytes, action-potential assays, and ex vivo heart models. Its selective profile supports mechanistic aging studies, arrhythmia prevention research, and ischemia-focused workflows while preserving a clear path from ion-current measurements to tissue-level phenotypes.

4-PBA: The Causal Logic of ER Stress

2026-08-24

4-Phenylbutyric acid is more than an ER-stress reagent: it can help translational researchers test whether proteostasis disruption is causally responsible for autophagic cell death. New liver-cancer findings illustrate how 4-PBA can turn pathway correlations into experimentally testable mechanisms.

Targeted BRD7 Demethylation in Nasopharyngeal Carcinoma

2026-08-23

The reference study develops a CRISPR/dCas9-TET1CD system to demethylate the BRD7 promoter and restore expression of this tumor-suppressive gene in nasopharyngeal carcinoma. Its combination of sgRNA2 and sgRNA5 produced the strongest transcriptional and antitumor effects, providing a mechanistic framework for locus-specific epigenetic intervention rather than global methylation disruption.

HyperFluor 488 Goat Anti-Rabbit IgG Guide

2026-08-22

HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody is a fluorescent secondary reagent for detecting rabbit primary antibodies in immunofluorescence, immunocytochemistry, flow cytometry, and fluorescence microscopy. It should not be used as a primary antibody, with non-rabbit primary antibodies, or in workflows that cannot tolerate its sodium azide-containing formulation without suitable buffer exchange and validation.

DiR (DiIC 18 (7)) for EV Tracking and Membrane Imaging

2026-08-22

Explore how DiR (DiIC 18 (7)) supports live cell membrane imaging, EV biodistribution studies, and long-term fluorescence tracking. This guide translates the Engage & Evasion EV study into practical assay design, controls, and interpretation strategies.

PFOS, Ferroptosis, and ER Stress in HK-2 Cells

2026-08-21

The reference study links perfluorooctane sulfonate exposure to human proximal tubular cell injury through coordinated ferroptosis-associated changes and activation of the endoplasmic reticulum stress pathway. Its integrated endpoint strategy provides a focused framework for investigating environmental nephrotoxicity while also clarifying which mechanistic questions remain unresolved.

Decitabine: From Methylation Biology to Translation

2026-08-20

Decitabine (5-Aza-2'-deoxycytidine) is more than a DNA methyltransferase inhibitor: it is a schedule-sensitive tool for connecting methylation biology, tumor suppressor gene reactivation, immune remodeling, and translational decision-making. This article examines the mechanistic rationale, toxicology boundaries, experimental design priorities, and strategic opportunities for hematopoietic malignancy research and solid tumor epigenetic studies.

v-Agatoxin-IVA and Neuronal Calcium Channel Diversity

2026-08-20

Sidach and Mintz showed that v-Agatoxin-IVA is not an exclusively high-affinity P-type calcium channel blocker: at micromolar exposure, it also inhibits a fraction of neuronal N-type and related high-threshold currents. The study demonstrates why toxin concentration, voltage dependence, and cell context must be integrated when assigning native calcium-channel identities.